BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

850 related articles for article (PubMed ID: 19116915)

  • 1. Genetic, immunologic, and immunohistochemical analysis of the programmed death 1/programmed death ligand 1 pathway in human systemic lupus erythematosus.
    Bertsias GK; Nakou M; Choulaki C; Raptopoulou A; Papadimitraki E; Goulielmos G; Kritikos H; Sidiropoulos P; Tzardi M; Kardassis D; Mamalaki C; Boumpas DT
    Arthritis Rheum; 2009 Jan; 60(1):207-18. PubMed ID: 19116915
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The programmed death 1/programmed death ligand 1 inhibitory pathway is up-regulated in rheumatoid synovium and regulates peripheral T cell responses in human and murine arthritis.
    Raptopoulou AP; Bertsias G; Makrygiannakis D; Verginis P; Kritikos I; Tzardi M; Klareskog L; Catrina AI; Sidiropoulos P; Boumpas DT
    Arthritis Rheum; 2010 Jul; 62(7):1870-80. PubMed ID: 20506224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of PDCD1 polymorphisms with childhood-onset systemic lupus erythematosus.
    Velázquez-Cruz R; Orozco L; Espinosa-Rosales F; Carreño-Manjarrez R; Solís-Vallejo E; López-Lara ND; Ruiz-López IK; Rodríguez-Lozano AL; Estrada-Gil JK; Jiménez-Sánchez G; Baca V
    Eur J Hum Genet; 2007 Mar; 15(3):336-41. PubMed ID: 17228327
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CTLA-4 gene polymorphism of exon 1(+49 A/G) in Turkish systemic lupus erythematosus patients.
    Ulker M; Yazisiz V; Sallakci N; Avci AB; Sanlioglu S; Yegin O; Terzioglu E
    Int J Immunogenet; 2009 Aug; 36(4):245-50. PubMed ID: 19602000
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression and function of inducible costimulator on peripheral blood T cells in patients with systemic lupus erythematosus.
    Yang JH; Zhang J; Cai Q; Zhao DB; Wang J; Guo PE; Liu L; Han XH; Shen Q
    Rheumatology (Oxford); 2005 Oct; 44(10):1245-54. PubMed ID: 15987711
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD134 expression on CD4+ T cells is associated with nephritis and disease activity in patients with systemic lupus erythematosus.
    Patschan S; Dolff S; Kribben A; Dürig J; Patschan D; Wilde B; Specker C; Philipp T; Witzke O
    Clin Exp Immunol; 2006 Aug; 145(2):235-42. PubMed ID: 16879242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of three systemic lupus erythematosus susceptibility factors, PD-1.3A, C4AQ0, and low levels of mannan-binding lectin, with autoimmune manifestations in Icelandic multicase systemic lupus erythematosus families.
    Kristjansdottir H; Saevarsdottir S; Gröndal G; Alarcón-Riquelme ME; Erlendsson K; Valdimarsson H; Steinsson K
    Arthritis Rheum; 2008 Dec; 58(12):3865-72. PubMed ID: 19035512
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of a programmed death 1 gene polymorphism with the development of rheumatoid arthritis, but not systemic lupus erythematosus.
    Lin SC; Yen JH; Tsai JJ; Tsai WC; Ou TT; Liu HW; Chen CJ
    Arthritis Rheum; 2004 Mar; 50(3):770-5. PubMed ID: 15022318
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of the functional relevance of a putative regulatory SNP of PDCD1, PD1.3, associated with systemic lupus erythematosus.
    Suarez-Gestal M; Ferreiros-Vidal I; Ortiz JA; Gomez-Reino JJ; Gonzalez A
    Genes Immun; 2008 Jun; 9(4):309-15. PubMed ID: 18401354
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Roles of CCR2 and CXCR3 in the T cell-mediated response occurring during lupus flares.
    Amoura Z; Combadiere C; Faure S; Parizot C; Miyara M; Raphaël D; Ghillani P; Debre P; Piette JC; Gorochov G
    Arthritis Rheum; 2003 Dec; 48(12):3487-96. PubMed ID: 14673999
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The analysis on single nucleotide polymorphism of PDCD1 and systemic lupus erythematous susceptibility among Han indigenous in Chinese population].
    Ye DQ; Yin J; Li XP; Zhang GQ; Zhang YQ; Wang Q; Liu HH
    Zhonghua Liu Xing Bing Xue Za Zhi; 2005 Sep; 26(9):698-701. PubMed ID: 16471222
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between the PD1.3A/G polymorphism of the PDCD1 gene and systemic lupus erythematosus in European populations: a meta-analysis.
    Liu JL; Zhang FY; Liang YH; Xiao FL; Zhang SQ; Cheng YL; Yuan CD; Chen QP; Yang S; Zhang XJ
    J Eur Acad Dermatol Venereol; 2009 Apr; 23(4):425-32. PubMed ID: 19220647
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human corneal endothelial cells expressing programmed death-ligand 1 (PD-L1) suppress PD-1+ T helper 1 cells by a contact-dependent mechanism.
    Sugita S; Usui Y; Horie S; Futagami Y; Yamada Y; Ma J; Kezuka T; Hamada H; Usui T; Mochizuki M; Yamagami S
    Invest Ophthalmol Vis Sci; 2009 Jan; 50(1):263-72. PubMed ID: 18775867
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bias in association studies of systemic lupus erythematosus susceptibility due to geographical variation in the frequency of a programmed cell death 1 polymorphism across Europe.
    Ferreiros-Vidal I; D'Alfonso S; Papasteriades C; Skopouli FN; Marchini M; Scorza R; Migliaresi S; Sebastiani GD; Endreffy E; Mavromati M; Kappou-Rigatou I; Ruzickova S; Dostal C; Schmidt RE; Witte T; Gomez-Reino JJ; Gonzalez A
    Genes Immun; 2007 Mar; 8(2):138-46. PubMed ID: 17230193
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lower expression levels of the programmed death 1 receptor on CD4+CD25+ T cells and correlation with the PD-1.3A genotype in patients with systemic lupus erythematosus.
    Kristjansdottir H; Steinsson K; Gunnarsson I; Gröndal G; Erlendsson K; Alarcón-Riquelme ME
    Arthritis Rheum; 2010 Jun; 62(6):1702-11. PubMed ID: 20178125
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A PD-1 polymorphism is associated with disease progression in multiple sclerosis.
    Kroner A; Mehling M; Hemmer B; Rieckmann P; Toyka KV; Mäurer M; Wiendl H
    Ann Neurol; 2005 Jul; 58(1):50-7. PubMed ID: 15912506
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Expression and clinical significance of inducible co-stimulator on peripheral blood T lymphocyte subsets in patients with systemic lupus erythematosus].
    Yang JH; Shen Q; Zhao DB; Cai Q; Han XH
    Zhonghua Yi Xue Za Zhi; 2005 Feb; 85(5):318-23. PubMed ID: 15854508
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased expression of soluble inducible costimulator ligand (ICOSL) in patients with systemic lupus erythematosus.
    Her M; Kim D; Oh M; Jeong H; Choi I
    Lupus; 2009 May; 18(6):501-7. PubMed ID: 19395451
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Porcine PD-L1: cloning, characterization, and implications during xenotransplantation.
    Jeon DH; Oh K; Oh BC; Nam DH; Kim CH; Park HB; Cho J; Lee JR; Lee DS; Lee G
    Xenotransplantation; 2007 May; 14(3):236-42. PubMed ID: 17489864
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of B-cell activating factor of the tumour necrosis factor family (BAFF) in T cells in active systemic lupus erythematosus: the role of BAFF in T cell-dependent B cell pathogenic autoantibody production.
    Morimoto S; Nakano S; Watanabe T; Tamayama Y; Mitsuo A; Nakiri Y; Suzuki J; Nozawa K; Amano H; Tokano Y; Kobata T; Takasaki Y
    Rheumatology (Oxford); 2007 Jul; 46(7):1083-6. PubMed ID: 17500077
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 43.